Abstract
Cardiovascular disease is a major disease affecting human health, and its pathogenesis is caused by many factors. Through the use of "omics" technology, precision medicine is playing an increasingly important role in the prevention and treatment of cardiovascular diseases. Dialectical treatment with traditional Chinese medicine (TCM will result in personalized treatment, which is consistent with precision medicine to a certain extent. However, due to the multitarget, multipath, and multistep characteristics of TCM, its mechanism of action is not easy to elucidate. Network pharmacology can be used to predict the mechanism, toxicity and metabolic characteristics of TCM. This review summarizes commonly used bioinformatics resources for cardiovascular diseases and TCM, as well as the opportunities and challenges of TCM in cardiovascular precision medicine, with special emphasis on network pharmacology methods.
Keywords: Cardiovascular disease, omics, traditional Chinese medicine, precision medicine, network pharmacology, transcriptome, metabolomics.
Current Pharmaceutical Design
Title:Traditional Chinese Medicine Network Pharmacology in Cardiovascular Precision Medicine
Volume: 27 Issue: 26
Author(s): Li Gao*, Min Cao, Jia-qi Li, Xue-mei Qin and Jiansong Fang*
Affiliation:
- Modern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan 030006,China
- Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405,China
Keywords: Cardiovascular disease, omics, traditional Chinese medicine, precision medicine, network pharmacology, transcriptome, metabolomics.
Abstract: Cardiovascular disease is a major disease affecting human health, and its pathogenesis is caused by many factors. Through the use of "omics" technology, precision medicine is playing an increasingly important role in the prevention and treatment of cardiovascular diseases. Dialectical treatment with traditional Chinese medicine (TCM will result in personalized treatment, which is consistent with precision medicine to a certain extent. However, due to the multitarget, multipath, and multistep characteristics of TCM, its mechanism of action is not easy to elucidate. Network pharmacology can be used to predict the mechanism, toxicity and metabolic characteristics of TCM. This review summarizes commonly used bioinformatics resources for cardiovascular diseases and TCM, as well as the opportunities and challenges of TCM in cardiovascular precision medicine, with special emphasis on network pharmacology methods.
Export Options
About this article
Cite this article as:
Gao Li*, Cao Min , Li Jia-qi , Qin Xue-mei and Fang Jiansong*, Traditional Chinese Medicine Network Pharmacology in Cardiovascular Precision Medicine, Current Pharmaceutical Design 2021; 27 (26) . https://dx.doi.org/10.2174/1381612826666201112142408
DOI https://dx.doi.org/10.2174/1381612826666201112142408 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Protein Kinases and Associated Pathways in Pluripotent State and Lineage Differentiation
Current Stem Cell Research & Therapy RNA Interference-Based Gene Silencing in Mice: The Development of a Novel Therapeutical Strategy
Current Pharmaceutical Design Molecular Docking Analysis of Flavonoid Compounds with Matrix Metalloproteinase- 8 for the Identification of Potential Effective Inhibitors
Letters in Drug Design & Discovery Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Endocannabinoid System in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Magnetic Materials for the Selective Analysis of Peptide and Protein Biomarkers
Current Medicinal Chemistry Epidermal Growth Factor Receptor Irreversible Inhibitors: Chemical Exploration of the Cysteine-Trap Portion
Mini-Reviews in Medicinal Chemistry Subject Index to Volume 9
Current Pharmaceutical Design Antioxidant Properties and Medicinal Uses of Some Crataegus Spp. (Hawthorn) Including <i>C. meyeri</i> and <i>C. pontica</i>
Current Nutrition & Food Science Towards Understanding the Roles of Prohibitins, Multi-Functional Regulator Proteins
Current Chemical Biology The Role of the Metabolism of Anticancer Drugs in Their Induced-Cardiotoxicity
Current Drug Metabolism Advances in Gene Therapy for Bladder Cancer
Current Gene Therapy Analysis of the Potential for HIV-1 Vpr as an Anti-Cancer Agent
Current HIV Research microRNA, Cancer and Cancer Chemoprevention
Current Molecular Pharmacology Targeting STAT1 in Both Cancer and Insulin Resistance Diseases
Current Protein & Peptide Science Targeting Proteasomal Pathways by Dietary Curcumin for Cancer Prevention and Treatment
Current Medicinal Chemistry Identifying Biomarkers of Lung Cancer in the Post-Genomic Era
Current Pharmacogenomics Functions of Antimicrobial Peptides in Vertebrates
Current Protein & Peptide Science The Contractile Properties of Airway Smooth Muscle: How their Defects can be Linked to Asthmatic Airway Hyperresponsiveness?
Current Respiratory Medicine Reviews Endoscopic Microscopy Using Optical Coherence Tomography
Current Medical Imaging